Immunohistochemical analysis showed absent estrogen receptor (ER) and progesterone receptor (PR) expression, weak-to-moderate androgen receptor (AR) positivity in 40 % of tumor cells, strong HER2 staining (3+), and a Ki-67 proliferation index of 25 %. This evidence concerns the gene ESR1 and neoplasm.